| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5927831 | American Heart Journal | 2016 | 11 Pages |
Abstract
In a trial of anticoagulated patients with AF, increasing screening SBP was independently associated with stroke and SE, and one-third of patients had uncontrolled hypertension. The relative effectiveness and safety of rivaroxaban versus warfarin were consistent across all levels of screening SBP. A single SBP may be an important factor in reducing the overall risk of stroke and SE in anticoagulated patients with AF.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sreekanth MD, Anne S. MS, W. Schuyler MD, Jonathan P. MD, MHS, Kenneth W. MD, Richard C. MD, Graeme J. MD, Scott D. MD, Christopher C. MD, Günter MD, Daniel E. MD, Keith A.A. MB, ChB, Manesh R. MD,